Centile Bioscience Inc. funding
Centile Bioscience Inc., a technology company based in Bethesda, MD (founded 2023), filed a Form D with the SEC on April 16, 2026 and reported $3.1M raised of a $4.1M offering.
Amount raised$3.1M
Offering size$4.1M
Filed with the SECApril 16, 2026
First saleMarch 20, 2026
IndustryOther Technology
SecuritiesEquity, Other
LocationBethesda, MD
Founded2023
Entity typeCorporation
Investors so far3
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Apr 16